Shares & Derivatives
China Animal Ltd…..just waiting for regulatory approval for its dual listing
By Kevin Scully-Financial Blog  •  November 4, 2010
[caption id="attachment_4054" align="alignright" width="150" caption="Photo by mikebaird"][/caption]Over the last few weeks three events have occured that in part have contributed to the steady rise in the price of China Animal over the last few days: a) 20 October 2010 - Fidelity (a large and well regarded global fund manager) increased its stake in China Animal from 7.95% to 8.05%.  China Animal already has three known insitutional investors - BlackStone, Fidelity and just below the 5% line Legg Mason. b) on 25 October 2010 - China Animal's subsidiary Biwei Antai which was acquired in May 2010 received regulatory approval to commence commercial production of vaccines for Animal Foot and Mouth disease.  This seems to be slightly delayed from earier guidance that such approval would be received in Q3-2010. Read more...
Read the full article
By Kevin Scully-Financial Blog
Kevin began his working life in the regional and economics division of the Ministry of Foreign Affairs. He then moved to the private sector analyzing equities before venturing out to start NRA Capital. After 25 years of watching stocks and living through financial disarray during the Pan Electric Crisis, the 1987 Crash, the Barings debacle, the Gulf War, Asian financial crisis - what can sub-prime do but add another scar to already bruised wounds. Ever since starting his blog, Kevin has been enthusiastically giving his personal views on the market. He discusses about equities, the market turmoil, and the broad economy.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance